Predictors of glycemic control among patients with Type 2 diabetes: A longitudinal study

Benoit, Stephen R.; Fleming, Regina; Philis-Tsimikas, Athena; Ming Ji
January 2005
BMC Public Health;2005, Vol. 5 Issue 1, p36
Academic Journal
Background: Diabetes is the sixth leading cause of death and results in significant morbidity. The purpose of this study is to determine what demographic, health status, treatment, access/quality of care, and behavioral factors are associated with poor glycemic control in a Type 2 diabetic, low-income, minority, San Diego population. Methods: Longitudinal observational data was collected on patients with Type 2 diabetes from Project Dulce, a program in San Diego County designed to care for an underserved diabetic population. The study sample included 573 patients with a racial/ethnic mix of 53% Hispanic, 7% black, 18% Asian, 20% white, and 2% other. We utilized mixed effects models to determine the factors associated with poor glycemic control using hemoglobin A1C (A1C) as the outcome of interest. A multi-step model building process was used resulting in a final parsimonious model with main effects and interaction terms. Results: Patients had a mean age of 55 years, 69% were female, the mean duration of diabetes was 7.1 years, 31% were treated with insulin, and 57% were obese. American Diabetes Association (ADA) recommendations for blood pressure and total cholesterol were met by 71% and 68%, respectively. Results of the mixed effects model showed that patients who were uninsured, had diabetes for a longer period of time, used insulin or multiple oral agents, or had high cholesterol had higher A1C values over time indicating poorer glycemic control. The younger subjects also had poorer control. Conclusion: This study provides factors that predict glycemic control in a specific low-income, multiethnic, Type 2 diabetic population. With this information, subgroups with high risk of disease morbidity were identified. Barriers that prevent these patients from meeting their goals must be explored to improve health outcomes.


Related Articles

  • SMS reminders- future in self-care management of diabetes mellitus? Riaz, Talha; Riaz, Harisz; Hussain, Syed A.; Kherani, Danish // Diabetology & Metabolic Syndrome;2012, Vol. 4 Issue 1, p31 

    Application of SMS in reminders of medical appointments and delivering medical tests is not new, however its focus on clinical interventions has just begun. Usage of tailored SMS reminders to increase adherence in treatment programs among sick individuals has allowed an interventional role in...

  • Reducing stress and supporting positive relations in families of young children with type 1 diabetes: A randomized controlled study for evaluating the effects of the DELFIN parenting program. Saßmann, Heike; de Hair, Mira; Danne, Thomas; Lange, Karin // BMC Pediatrics;2012, Vol. 12 Issue 1, p152 

    Background: To assess initial efficacy and feasibility of a structured behavioural group training (DELFIN) for parents of children with diabetes type 1, in order to reduce parenting stress and to improve parenting skills. Methods: A randomized controlled study was conducted between July 2008 and...

  • "The Logic of Care" -- Parents' perceptions of the educational process when a child is newly diagnosed with type 1 diabetes. Jönsson, Lisbeth; Hallström, Inger; Lundqvist, Anita // BMC Pediatrics;2012, Vol. 12 Issue 1, p165 

    Background: The number of new cases of type 1 diabetes mellitus (T1DM) has increased substantially in recent years and it is now one of the most common long-term endocrine disorders in childhood. In Sweden the child and family are hospitalised in accordance with the national guidelines for one...

  • Diabetes Induced Changes in Rat Mesenchymal Stem Cells. Stolzing, Alexandra; Sellers, Donna; Llewelyn, Owen; Scutt, Andy // Cells Tissues Organs;2010, Vol. 191 Issue 6, p453 

    Diabetes mellitus, the single most important cause of vascular disease in the industrialized world, is also associated with bone loss and impaired fracture healing. Mesenchymal stem cells (MSCs) have the potential to differentiate into osteoblasts, chondrocytes and adipocytes and other...

  • Hypothesis 1. Depression is a risk factor for the development of type 2 diabetes. Freedland, Kenneth E. // Diabetes Spectrum;Summer2004, Vol. 17 Issue 3, p150 

    Presents a commentary on the study "Depression and Risk for Onset of Type II Diabetes: A Prospective Population-based Study," by J. Gallo, L. Pratt, W. W. Eaton and D. E. Ford. Methods used in the study; Risk of developing diabetes among depressed persons; Other studies about diabetes.

  • Can Saliva be a Marker for Predicting Type 1 Diabetes Mellitus?–A Pilot Study. Nagalaxmi, V.; Priyanka, V. // Journal of Indian Academy of Oral Medicine & Radiology;Oct-Dec2012, Vol. 23 Issue 4, p579 

    Aim: To estimate and correlate salivary glucose levels with serum glucose levels in type 1 diabetes mellitus patients and healthy controls. Materials and methods: Fifty type 1 diagnosed diabetes mellitus patients and 50 age- and sex-matched healthy controls were included in the study. The...

  • Mesh Exposure and Associated Risk Factors in Women Undergoing Transvaginal Prolapse Repair with Mesh. Frankman, Elizabeth A.; Alperin, Marianna; Sutkin, Gary; Meyn, Leslie; Zyczynski, Halina M. // Obstetrics & Gynecology International;2013, p1 

    Objective. To determine frequency, rate, and risk factors associated with mesh exposure in women undergoing transvaginal prolapse repair with polypropylene mesh. Methods. Retrospective chart review was performed for all women who underwent Prolift Pelvic Floor Repair System (Gynecare,...

  • Qualitative evaluation of a diabetes electronic decision support tool: views of users. Qing Wan; Makeham, Meredith; Zwar, Nicholas A.; Petche, Susanna // BMC Medical Informatics & Decision Making;2012, Vol. 12 Issue 1, p61 

    Background: Quality care of type 2 diabetes is complex and requires systematic use of clinical data to monitor care processes and outcomes. An electronic decision support (EDS) tool for the management of type 2 diabetes in primary care was developed by the Australian Pharmaceutical Alliance. The...

  • Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis. Reynier, F.; Pachot, A.; Paye, M.; Xu, Q.; Turrel-Davin, F.; Petit, F.; Hot, A.; Auffray, C.; Bendelac, N.; Nicolino, M.; Mougin, B.; Thivolet, C. // Genes & Immunity;Apr2010, Vol. 11 Issue 3, p269 

    Understanding the pathogenesis of type-I diabetes (T1D) is hindered in humans by the long autoimmune process occurring before clinical onset and by the difficulty to study the pancreas directly. Alternatively, exploring body fluids and particularly peripheral blood can provide some insights....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics